Ausgabe 11/2011
Inhalt (12 Artikel)
Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma
Adam J. Bograd, Kei Suzuki, Eva Vertes, Christos Colovos, Eduardo A. Morales, Michel Sadelain, Prasad S. Adusumilli
Dual biological effects of the cytokines interleukin-10 and interferon-γ
Cailin Moira Wilke, Shuang Wei, Lin Wang, Ilona Kryczek, John Kao, Weiping Zou
Priming with very low-affinity peptide ligands gives rise to CD8+ T-cell effectors with enhanced function but with greater susceptibility to transforming growth factor (TGF)β-mediated suppression
Jeremy A. O’Sullivan, Andrew Zloza, Frederick J. Kohlhapp, Tamson V. Moore, Andrew T. Lacek, Nickolai O. Dulin, José A. Guevara-Patiño
Vaccination of patients with cutaneous melanoma with telomerase-specific peptides
Robert E. Hunger, Kristin Kernland Lang, Carrie J. Markowski, Sissel Trachsel, Mona Møller, Jon A. Eriksen, Anne-Marie Rasmussen, Lasse R. Braathen, Gustav Gaudernack
Comprehensive immunological analyses of colorectal cancer patients in the phase I/II study of quickly matured dendritic cell vaccine pulsed with carcinoembryonic antigen peptide
Mitsuru Sakakibara, Tatsuya Kanto, Michiyo Hayakawa, Shoko Kuroda, Hideki Miyatake, Ichiyo Itose, Masanori Miyazaki, Naruyasu Kakita, Koyo Higashitani, Tokuhiro Matsubara, Naoki Hiramatsu, Akinori Kasahara, Tetsuo Takehara, Norio Hayashi
Prostaglandin E2 (PGE2) suppresses natural killer cell function primarily through the PGE2 receptor EP4
Dawn Holt, Xinrong Ma, Namita Kundu, Amy Fulton
Increased prevalence of regulatory T cells in the lung cancer microenvironment: a role of thymic stromal lymphopoietin
Hui Li, Hua Zhao, Jinpu Yu, Yanjun Su, Shui Cao, Xiumei An, Xiubao Ren
Vaccination with CD133+ melanoma induces specific Th17 and Th1 cell–mediated antitumor reactivity against parental tumor
Takao Miyabayashi, Hiroshi Kagamu, Jun Koshio, Kosuke Ichikawa, Junko Baba, Satoshi Watanabe, Hiroshi Tanaka, Junta Tanaka, Hirohisa Yoshizawa, Koh Nakata, Ichiei Narita
Poly(I:C)-induced tumour cell death leads to DC maturation and Th1 activation
Edit Kovalcsik, Katie Lowe, Mike Fischer, Angus Dalgleish, Mark D. Bodman-Smith
Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™
Theo Nicholaou, Weisan Chen, Ian D. Davis, Heather M. Jackson, Nektaria Dimopoulos, Catherine Barrow, Judy Browning, Duncan MacGregor, David Williams, Wendie Hopkins, Eugene Maraskovsky, Ralph Venhaus, Linda Pan, Eric W. Hoffman, Lloyd J. Old, Jonathan Cebon
Differential down-modulation of HLA class I and II molecule expression on human tumor cell lines upon in vivo transfer
Riccardo Turrini, Anna Merlo, Riccardo Dolcetti, Paola Zanovello, Antonio Rosato
“Tumor immunology meets oncology (TIMO) VII” from 15th to 16th of April 2011 in Halle/Saale, Germany
Juergen Bukur, Elfriede Noessner, Barbara Seliger